Researchers at Stanford University have found that recombinant osteopontin (SPP1) protein reduces foreign body response (FBR) and thereby facilitates successful integration and function of implantable devices.
Stanford scientists have developed a novel hydrogel for long-term drug delivery of an Activator Protein 1 (AP-1) inhibitor for the prevention of post-surgical abdominal adhesion.
Researchers in the Appel lab have developed hydrogels for tumor inoculation that improve precision and statistical power in preclinical mouse models of cancer.
Stanford researchers have developed a library of polymeric hydrogel formulations to prevent and/or reduce biofouling on implanted sensors and medical devices.
Researchers at Stanford and their colleagues have developed compositions and methods for producing improved lipid nanodiscs that enable more effective studies of membrane proteins. Traditionally, scientists have studied proteins using x-ray crystallography.
Stanford and IBM researchers have recently patented methods for making a new class of multi-branched macromolecules with well-defined molecular weights and surface structures.